Texas earns a D, ranking 36th of 51 states. Nearly 30.5 million people live here, across 254 counties from El Paso to Beaumont. This is the state with the second-most active clinical trials in the country. It also has the highest uninsured rate of any state in the nation. That contradiction isn't an accident. It's the defining fact of Texas health in 2026: extraordinary medical infrastructure built atop a population systematically blocked from using it.
The national average for uninsured adults is 11.4%. In Texas, it's 20.7%. Nearly double. That's roughly six million people who go without coverage, skip checkups, ration medications, and hope nothing serious happens. Everything else in this report flows from that number.
The obesity rate, 37.6%, essentially matches the national average. What doesn't match is inactivity: nearly one in three adults gets no leisure-time physical activity, three points above the national rate. Obesity plus inactivity drives the cardiovascular load. The state's top-prescribed drugs tell the story plainly: Atorvastatin Calcium, Amlodipine Besylate, and Lisinopril. Cholesterol. Blood pressure. Blood pressure and heart failure. These aren't mysterious diseases. They're the predictable endpoint of a sedentary, high-obesity population with limited access to preventive care.
Smoking is, genuinely, below average. At 14.9%, Texas smokes less than the national rate of 16.1%. It won't override the cardiovascular burden, but lung disease and COPD aren't as dominant here as in Appalachian states where tobacco culture runs deep. That's a real advantage. It's also not enough.
The uninsured rate shows up directly in self-reported health: 24.6% of Texas adults say they're in fair or poor health, versus 21.3% nationally. That's one in four people describing themselves as unwell. Median household income sits at $63,467, below the national median of $65,754. More than one in five Texas children grows up in poverty. Those children carry that disadvantage into adulthood. The income inequality index of 4.72 tells you the wealth exists in Texas. It just isn't distributed where the health burden is.
The CDC divergence chart for Texas reads like a case study in what happens when insurance disappears. The state's biggest deviation from national norms: the uninsured rate, running 9.3 points above average. Everything downstream follows.
Dental visits are 6.4 points below national rates. Only 51.4% of Texans saw a dentist last year, versus 57.8% nationally. Dental care is typically the first thing dropped when coverage lapses, and the consequences compound: untreated oral disease links to cardiovascular disease, diabetes complications, and preterm birth. The pattern extends to cancer screening: colorectal screening reaches just 55.5% of eligible Texans versus 60.7% nationally. That's a five-point deficit on a test that catches one of the most treatable cancers. Routine checkups happen for only 73.4% of adults versus 76.3% nationally. These gaps aren't catastrophic individually. Together, they describe a population systematically deferring the care that catches illness early.
Some divergences run the other way. Texas records lower rates of arthritis, cancer diagnoses, and asthma than the national average. The state's younger demographic explains part of this. But part of it is almost certainly underdiagnosis. Uninsured patients don't get fewer diseases. They get fewer diagnoses.
Diabetes affects 13.6% of Texas adults, a full point above the national rate of 12.4%. That gap is visible in the more than four million Metformin prescriptions filled here. Sleep deprivation runs quietly above average too: 38.8% of adults report short sleep duration versus 36.7% nationally. That number doesn't make headlines, but it sits at the root of obesity, cardiovascular disease, and mental health deterioration.
The conditions that create illness exist upstream of any hospital. The social picture for Texas shows what's straining the system before patients ever reach a clinic: food insecurity concentrated in low-income rural counties, housing instability among the uninsured and working poor, transportation gaps that turn a specialist appointment into a day-long undertaking or simply an impossibility.
Roughly 22% of Texas children live in poverty, and the income inequality index shows the spread. That inequality concentrates in specific places. The colonias along the Rio Grande, unincorporated subdivisions where tens of thousands of residents lack reliable water or sewage infrastructure. East Texas timber country. The Panhandle's isolated agricultural communities, where the last hospital may be an hour away and the nearest mental health provider considerably farther.
Houston, the most racially diverse large city in the country, has no zoning code. The result is a mix of affordable sprawl and informal housing that often lacks stable utilities and consistent health services. San Antonio's South Side and Dallas's southern sectors carry concentrated poverty that shapes health outcomes as directly as any clinical variable.
Transportation is the invisible barrier. Texas built itself around the car, and large portions of rural Texas have no meaningful public transit. A patient in the colonias near Laredo, or in a small farming town in the South Plains, faces a 60 to 90-minute drive to reach a specialist. Assuming they have insurance, a car, and an employer who'll give them time off. For the uninsured, those barriers don't need to stack. Any one is enough.
Texas has 343,625 total providers. At 11.3 per 1,000 residents, the state ranks worse than 49 others. Massachusetts, ranked second overall, has 26.5 providers per 1,000. More than double. For a state this large and this spread out, that gap isn't a statistic. It's a waiting room.
Of the 112,720 providers enrolled in CMS, roughly 92% accept Medicare, a rate that still places Texas worse than 45 other states. Only 17,319 providers offer telehealth services, about 15% of CMS-enrolled providers. In a state where a patient in the Trans-Pecos might be 150 miles from the nearest specialist, that telehealth penetration represents a significant failure of rural reach.
The shortage data makes the access crisis concrete. There are 747 primary care shortage areas in Texas. Mental health shortage areas number 348, leaving roughly 41 million people underserved. Dental shortage areas: 228, affecting nearly 19.5 million. So where are the doctors? The top specialty category statewide is nurse practitioners at 39,320. Family practice physicians number just 11,599. That's roughly one for every 2,600 Texans, before accounting for the fact that most of them are in Houston, Dallas, and Austin.
Texas hospitals see 637.1 emergency room visits per 1,000 residents. That rate reflects what happens when primary care is scarce and one in five adults is uninsured: the emergency room becomes the default. Not because patients prefer it. Because it's the one place that can't turn them away.
Uninsured patients without primary care physicians arrive for conditions that could have been managed weeks earlier: diabetic crises that started as poorly controlled blood sugar, hypertensive emergencies that started as untreated high blood pressure, infections that started as minor wounds. Each visit costs more, takes longer, and produces worse outcomes than the preventive care that never happened. The ER isn't a safety net here. It's a last resort masquerading as one.
Hospital readmissions run at roughly 20%, though that number should be read as directional rather than precise. Administrative readmission data varies significantly across institutions and populations. What it signals is that discharge planning remains under pressure in a system where many patients leave the hospital without a provider to follow up with.
The financial structure of Texas health care is built on a fault line: the uninsured rate. At 20.7%, Texas is worst in the nation. The distance from Massachusetts's 5.2% isn't just statistical. Massachusetts achieved near-universal coverage through a state mandate years before the Affordable Care Act existed. Texas was one of the original states to refuse Medicaid expansion, a decision held for over a decade, leaving a coverage gap affecting hundreds of thousands of adults who earn too much for traditional Medicaid and too little for marketplace subsidies.
The prescription data tells the disease story in numbers. Texas generated 190 million total drug claims at a cost of $32 billion. Atorvastatin Calcium leads with 9 million claims, managing cholesterol in a high-cardiovascular-burden population. Levothyroxine Sodium follows at 6.3 million claims, reflecting widespread hypothyroidism. Gabapentin's 4.8 million claims span epilepsy, nerve pain, and off-label anxiety treatment, a drug that often appears in populations with limited specialist access. Metformin HCl at 4.2 million claims is the clearest signal of the state's diabetes burden, a disease both preventable and devastating when undertreated.
The average Medicare procedure costs $74.63. Providers bill an average of $430.03. Nearly six to one. For the Medicare patient, the system negotiates the gap. For the uninsured patient, the $430 is what arrives in the mail. A diagnosis becomes a financial crisis before it becomes a clinical one.
The pharmaceutical industry paid 84,013 Texas providers a total of $188.5 million across more than 1.35 million payments. The breakdown on payment types tells the story of how the industry operates at scale: speaker fees and faculty compensation led dollar volume at $45.5 million across 19,483 payments. Consulting fees added $36.6 million. Food and beverage, the channel that funds medical education lunches and detail visits, accounted for $36.5 million across 1.25 million interactions.
Royalties and licensing are a different category entirely. They generated $34 million across just 661 payments, averaging more than $51,000 per transaction. That concentration lives in the academic medical centers where patentable science originates: MD Anderson, UT Southwestern, Baylor College of Medicine. These institutions produce discoveries that generate royalty streams alongside their clinical and research missions.
The average across all payments is $139. That's the detail visit: a brief meeting, a sample drop-off, a catered lunch. More than a million of those interactions happen in Texas every year. The 1,103 companies making payments aren't a fringe of bad actors. This is the standard operating rhythm of how drugs reach prescribers, at a scale that shapes prescribing patterns in ways largely invisible to patients.
There are 309 actively excluded providers in Texas, currently barred from federal health programs for fraud, abuse, or patient harm. The state ranks worse than 47 others on this measure. Given 343,625 total providers, the per-capita rate isn't dramatic. But 309 represents real accountability failures in a system already stretched thin, and the historic exclusion count of 5,847 suggests the pattern isn't new.
More consequential for daily access: 3,469 providers have opted out of Medicare entirely, a rate of 10.1 per 1,000. Opt-outs concentrate in specialties where cash-pay practices are viable: concierge medicine, elective procedures, practices with clientele wealthy enough to pay out of pocket. For Medicare patients, disproportionately older, lower-income, and sicker, a shrinking pool of participating providers means longer waits and longer drives. Texas already ranks worse than 45 other states on Medicare acceptance. The opt-out trend moves in exactly the wrong direction.
Texas ranks second in the nation on active clinical trials with 40,768. That's 34 positions above the state's overall health ranking, and it's the most striking disconnect in this entire report. Wyoming, ranked 20th overall, has 571 active trials. Texas has 71 times as many.
NIH funding backs that infrastructure: $284 million across 694 grants, ranking sixth nationally. Wyoming receives $439,246. The money flows to Texas's academic medical centers: UT Southwestern Medical Center in Dallas, which has produced six Nobel laureates in chemistry and medicine; MD Anderson Cancer Center in Houston, consistently ranked the nation's top cancer treatment and research institution; Baylor College of Medicine; and the expanding health sciences programs at Texas A&M.
But who can actually reach these trials? Clinical trial participation requires transportation, time off work, and often insurance to cover associated care. In a state where one in five adults is uninsured and primary care is severely constrained, the population carrying the greatest disease burden is the least likely to access the trials designed to address it. The research enterprise Texas has built is real. The gap between that enterprise and the people who most need it is also real.
Texas's internal gap is among the most extreme in the country. Collin County north of Dallas records a death rate of 4,576 per 100,000 and a median household income of $120,149. Stonewall County in the Rolling Plains has a death rate of 21,829. Nearly five times higher. A 4.8x gap means where you're born in Texas is among the most consequential health determinants you'll face in your life.
Denton County and Williamson County, anchoring the suburban rings of Dallas-Fort Worth and Austin, perform similarly to Collin: death rates below 5,200, median incomes above $107,000, proximity to major academic medical centers, educated workforces with employer-sponsored insurance. These are the counties that pull the state's averages toward national norms on income and health behaviors. They're not representative of Texas.
Red River County in Northeast Texas carries a death rate of 19,571 and a median income of $49,265. Sabine County in deep East Texas: 16,290 deaths per 100,000, $58,723 median income. These communities are aging, isolated from major hospital systems, and losing primary care physicians without replacing them. The dot plot makes this visible at scale: the outliers aren't really outliers. The gap runs through the whole state. The 254 counties in Texas span everything from Harris County (Houston, 4.8 million people, fourth-largest city in the country) to counties with fewer than 200 residents. No statewide policy fits both. That complexity is part of why the divide has persisted. But complexity isn't the cause. Policy is.
Texas has built one of the most sophisticated medical research ecosystems on earth while simultaneously leading the nation in leaving its people uninsured. These aren't separate stories happening in different corners of a big state. They're the same story. The same policy environment that made Texas hospitable to academic medicine, pharmaceutical investment, and private health enterprise also produced the sustained refusal to expand Medicaid and the provider shortages in rural and border communities that have made the Rio Grande Valley and East Texas among the most medically underserved regions in the country.
The 40,768 clinical trials and $284 million in NIH funding are genuine achievements. MD Anderson extends survival for cancer patients worldwide. UT Southwestern has produced foundational science in cardiovascular and metabolic disease. The talent concentrated in the Texas Medical Center is a real state asset. But it doesn't reach the 30-year-old uninsured woman in the colonias near McAllen or the 55-year-old farmer in Stonewall County managing untreated hypertension with over-the-counter remedies. Not because the science doesn't exist. Because the pathway from that science to that patient was never built.
That's not a gap. That's a policy decision with a body count. The D grade isn't a verdict on Texas's medical talent. It's a verdict on who that talent is available to.